Cite
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.
MLA
Hallow, Karen M., et al. “Why Do SGLT2 Inhibitors Reduce Heart Failure Hospitalization? A Differential Volume Regulation Hypothesis.” Diabetes, Obesity & Metabolism, vol. 20, no. 3, Mar. 2018, pp. 479–87. EBSCOhost, https://doi.org/10.1111/dom.13126.
APA
Hallow, K. M., Helmlinger, G., Greasley, P. J., Mcmurray, J. J. V., & Boulton, D. W. (2018). Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes, Obesity & Metabolism, 20(3), 479–487. https://doi.org/10.1111/dom.13126
Chicago
Hallow, Karen M., Gabriel Helmlinger, Peter J. Greasley, John J. V. Mcmurray, and David W. Boulton. 2018. “Why Do SGLT2 Inhibitors Reduce Heart Failure Hospitalization? A Differential Volume Regulation Hypothesis.” Diabetes, Obesity & Metabolism 20 (3): 479–87. doi:10.1111/dom.13126.